Long-term therapy in COPD: any evidence of adverse effect on bone?

References

• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
   PubMed Web of Science ®Google Scholar
• DecramerMRennardSTroostersTCOPD as a lung disease with systemic consequences – clinical impact, mechanisms, and potential for early interventionCOPD20085423525618671149
   PubMedGoogle Scholar
• BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
   PubMed Web of Science ®Google Scholar
• SchlaichCMinneHWBrucknerTReduced pulmonary function in patients with spinal osteoporotic fracturesOsteoporos Int1998832612679797911
   PubMed Web of Science ®Google Scholar
• PapaioannouAParkinsonWFerkoNPrevalence of vertebral fractures among patients with chronic obstructive pulmonary disease in CanadaOsteoporos Int2003141191391714551675
   PubMed Web of Science ®Google Scholar
• PuhanMABachmannLMKleijnenJterRGKesselsAGInhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysisBMC Med20097219144173
   PubMed Web of Science ®Google Scholar
• CummingsSRMeltonLJEpidemiology and outcomes of osteoporotic fracturesLancet200235993191761176712049882
   PubMed Web of Science ®Google Scholar
• MatkovicVJelicTWardlawGMTiming of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional modelJ Clin Invest19949327998088113412
   PubMed Web of Science ®Google Scholar
• BergerCLangsetmoLJosephLChange in bone mineral density as a function of age in women and men and association with the use of antiresorptive agentsCMAJ2008178131660166818559803
   PubMed Web of Science ®Google Scholar
• RiggsBLMeltonLJRobbRAA population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and menJ Bone Miner Res200823220521417937534
   PubMed Web of Science ®Google Scholar
• HolroydCCooperCDennisonEEpidemiology of osteoporosisBest Pract Res Clin Endocrinol Metab200822567168519028351
   PubMed Web of Science ®Google Scholar
• Dawson-HughesBTostesonANMeltonLJIIIImplications of absolute fracture risk assessment for osteoporosis practice guidelines in the USAOsteoporos Int200819444945818292975
   PubMed Web of Science ®Google Scholar
• NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and TherapyJAMA20012856785795
   PubMed Web of Science ®Google Scholar
• Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study GroupWorld Health Organ Tech Rep Ser199484311297941614
   PubMed Web of Science ®Google Scholar
• CummingsSRBatesDBlackDMClinical use of bone densitometry: scientific reviewJAMA2002288151889189712377088
   PubMed Web of Science ®Google Scholar
• SteigerPCummingsSRBlackDMSpencerNEGenantHKAge-related decrements in bone mineral density in women over 65J Bone Miner Res1992766256321414480
   PubMed Web of Science ®Google Scholar
• SirisESChenYTAbbottTABone mineral density thresholds for pharmacological intervention to prevent fracturesArch Intern Med2004164101108111215159268
   PubMedGoogle Scholar
• BergerCLangsetmoLJosephLAssociation Between Change in Bone Mineral Density (BMD) and Fragility Fracture in Women and MenJ Bone Miner Res2008
   Google Scholar
• KanisJADiagnosis of osteoporosis and assessment of fracture riskLancet200235993211929193612057569
   PubMed Web of Science ®Google Scholar
• KanisJAGluerCCAn update on the diagnosis and assessment of osteoporosis with densitometry. Committee of Scientific Advisors, International Osteoporosis FoundationOsteoporos Int200011319220210824234
   PubMed Web of Science ®Google Scholar
• OrimoHSugiokaYFukunagaMThe Committee of the Japanese Society for Bone and Mineral Research for Development of Diagnostic criteria of Osteoporosis: Diagnostic criteria of primary osteoporosisJ Bone Miner Metab199816139150
   Web of Science ®Google Scholar
• CummingsSRBlackDMNevittMCBone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research GroupLancet1993341883772758093403
   PubMed Web of Science ®Google Scholar
• MarshallDJohnellOWedelHMeta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fracturesBMJ1996183127041125412598634613
   PubMed Web of Science ®Google Scholar
• BlackDMCummingsSRGenantHKNevittMCPalermoLBrownerWAxial and appendicular bone density predict fractures in older womenJ Bone Miner Res1992766336381414481
   PubMed Web of Science ®Google Scholar
• WasnichRBone mass measurement: prediction of riskAm J Med1993955A6S10S8256798
   PubMed Web of Science ®Google Scholar
• GluerCCQuantitative ultrasound techniques for the assessment of osteoporosis: expert agreement on current status. The International Quantitative Ultrasound Consensus GroupJ Bone Miner Res1997128128012089258759
   PubMed Web of Science ®Google Scholar
• HansDrgent-MolinaPSchottAMUltrasonographic heel measurements to predict hip fracture in elderly women: the EPIDOS prospective studyLancet199634890265115148757153
   PubMed Web of Science ®Google Scholar
• VriezeAde GreefMHWijkstraPJWempeJBLow bone mineral density in COPD patients related to worse lung function, low weight and decreased fat-free massOsteoporos Int20071891197120217347789
   PubMed Web of Science ®Google Scholar
• NayakSOlkinILiuHMeta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosisAnn Intern Med20061441183284116754925
   PubMed Web of Science ®Google Scholar
• JonesAFayJKBurrMStoneMHoodKRobertsGInhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary diseaseCochrane Database Syst Rev20021CD00353711869676
   PubMedGoogle Scholar
• BarnesPJPedersenSBusseWWEfficacy and safety of inhaled corticosteroids. New developmentsAm J Respir Crit Care Med19981573 Pt 2S1S539520807
   PubMed Web of Science ®Google Scholar
• ScanlonPDConnettJEWiseRALoss of bone density with inhaled triamcinolone in Lung Health Study IIAm J Respir Crit Care Med2004170121302130915374846
   PubMed Web of Science ®Google Scholar
• CivitelliRRmamento-VillarealRNapoliNBone turnover markers: understanding their value in clinical trials and clinical practiceOsteoporos Int200920684385119190842
   PubMed Web of Science ®Google Scholar
• JohnellOPauwelsRLofdahlCGBone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide TurbuhalerEur Respir J20021961058106312108857
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• SosaMJodarESaavedraPPostmenopausal Canarian women receiving oral glucocorticoids have an increased prevalence of vertebral fractures and low values of bone mineral density measured by quantitative computer tomography and dual X-ray absorptiometry, without significant changes in parathyroid hormoneEur J Intern Med2008191515618206602
   PubMed Web of Science ®Google Scholar
• MinisolaSDelFRPiemonteSBiochemical markers in glucocorticoid-induced osteoporosisJ Endocrinol Invest2008317 Suppl283218791348
   PubMedGoogle Scholar
• LofthusCMOsnesEKFalchJAEpidemiology of hip fractures in Oslo, NorwayBone200129541341811704490
   PubMed Web of Science ®Google Scholar
• CauleyJALuiLYEnsrudKEBone mineral density and the risk of incident nonspinal fractures in black and white womenJAMA2005293172102210815870413
   PubMed Web of Science ®Google Scholar
• ChiuGRAraujoABTravisonTGHallSAMcKinlayJBRelative contributions of multiple determinants to bone mineral density in menOsteoporos Int2009325 [Epub ahead of print]
   Web of Science ®Google Scholar
• LindsayRSilvermanSLCooperCRisk of new vertebral fracture in the year following a fractureJAMA2001285332032311176842
   PubMed Web of Science ®Google Scholar
• PapaioannouAKennedyCCCranneyARisk factors for low BMD in healthy men age 50 years or older: a systematic reviewOsteoporos Int200920450751818758880
   PubMed Web of Science ®Google Scholar
• YanbaevaDGDentenerMACreutzbergECWesselingGWoutersEFSystemic effects of smokingChest200713151557156617494805
   PubMed Web of Science ®Google Scholar
• LanghammerAJohnsenRGulsvikAHolmenTLBjermerLSex differences in lung vulnerability to tobacco smokingEur Respir J20032161017102312797498
   PubMed Web of Science ®Google Scholar
• Ben-ZakenCSParePDManSFSinDDThe growing burden of chronic obstructive pulmonary disease and lung cancer in women: examining sex differences in cigarette smoke metabolismAm J Respir Crit Care Med2007176211312017413125
   PubMedGoogle Scholar
• RutherfordOMIs there a role for exercise in the prevention of osteoporotic fractures?Br J Sports Med199933637838610597845
   PubMed Web of Science ®Google Scholar
• FrancoCBPaz-FilhoGGomesPEChronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin DOsteoporos Int2009320 [Epub ahead of print]
   Web of Science ®Google Scholar
• JanssensWLehouckACarremansCBouillonRMathieuCDecramerMVitamin D Beyond Bones in COPD: Time to ActAm J Respir Crit Care Med2009179863063619164701
   PubMed Web of Science ®Google Scholar
• HannanMTFelsonDTwson-HughesBRisk factors for longitudinal bone loss in elderly men and women: the Framingham Osteoporosis StudyJ Bone Miner Res200015471072010780863
   PubMed Web of Science ®Google Scholar
• ZhaiGHartDJValdesAMNatural history and risk factors for bone loss in postmenopausal Caucasian women: a 15-year follow-up population-based studyOsteoporos Int20081981211121718305885
   PubMed Web of Science ®Google Scholar
• ForsmoSLanghammerAScheiBPast and current weight change and forearm bone loss in middle-aged women: the Nord-Trondelag Health Study, NorwayMenopause2009515 [Epub ahead of print]
   Web of Science ®Google Scholar
• OmslandTKScheiBGronskagABWeight loss and distal forearm fractures in postmenopausal women: The Nord-Trondelag health study, NorwayOsteoporos Int200937 [Epub ahead of print]
   Web of Science ®Google Scholar
• AgustiASorianoJBCOPD as a systemic diseaseCOPD20085213313818415812
   PubMedGoogle Scholar
• van StaaTPGeusensPPolsHAdeLCLeufkensHGCooperCA simple score for estimating the long-term risk of fracture in patients using oral glucocorticoidsQJM200598319119815728400
   PubMed Web of Science ®Google Scholar
• de VriesFBrackeMLeufkensHGLammersJWCooperCvan StaaTPFracture risk with intermittent high-dose oral glucocorticoid therapyArthritis Rheum200756120821417195223
   PubMed Web of Science ®Google Scholar
• van StaaTPLeufkensHGAbenhaimLZhangBCooperCUse of oral corticosteroids and risk of fracturesJ Bone Miner Res2000156993100010841167
   PubMed Web of Science ®Google Scholar
• VestergaardPRejnmarkLMosekildeLFracture risk associated with systemic and topical corticosteroidsJ Intern Med2005257437438415788008
   PubMed Web of Science ®Google Scholar
• SeemanEOsteoporosis: trials and tribulationsAm J Med19971032 A74S87S9302899
   PubMedGoogle Scholar
• WisniewskiAFLewisSAGreenDJMaslankaWBurrellHTattersfieldAECross sectional investigation of the effects of inhaled corticosteroids on bone density and bone metabolism in patients with asthmaThorax199752108538609404371
   PubMed Web of Science ®Google Scholar
• SinDDManJPManSFThe risk of osteoporosis in Caucasian men and women with obstructive airways diseaseAm J Med20031141101412543283
   PubMed Web of Science ®Google Scholar
• LekamwasamSTrivediDPKhawKTAn association between respiratory function and hip bone mineral density in older men: a cross-sectional studyOsteoporos Int200516220420715197543
   PubMed Web of Science ®Google Scholar
• EastellRTreatment of postmenopausal osteoporosisN Engl J Med1998338117367469494151
   PubMed Web of Science ®Google Scholar
• BiskobingDMCOPD and osteoporosisChest2002121260962011834678
   PubMed Web of Science ®Google Scholar
• OharaTHiraiTMuroSRelationship between pulmonary emphysema and osteoporosis assessed by CT in patients with COPDChest200813461244124918641115
   PubMed Web of Science ®Google Scholar
• de VriesFvan StaaTPBrackeMSCooperCLeufkensHGLammersJWSeverity of obstructive airway disease and risk of osteoporotic fractureEur Respir J200525587988415863646
   PubMed Web of Science ®Google Scholar
• BoltonCEIonescuAAShielsKMAssociated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2004170121286129315374843
   PubMed Web of Science ®Google Scholar
• KatsuraHKidaKA comparison of bone mineral density in elderly female patients with COPD and bronchial asthmaChest200212261949195512475832
   PubMed Web of Science ®Google Scholar
• KjensliAMowinckelPRygMSFalchJALow bone mineral density is related to severity of chronic obstructive pulmonary diseaseBone200740249349717049326
   PubMed Web of Science ®Google Scholar
• LiLBrennanKJGaughanJPCiccolellaDEKuzmaAMCrinerGJAfrican Americans and men with severe COPD have a high prevalence of osteoporosisCOPD20085529129718972277
   PubMedGoogle Scholar
• NutiRSivieroPMaggiSVertebral fractures in patients with chronic obstructive pulmonary disease: the EOLO StudyOsteoporos Int200920698999818931817
   PubMed Web of Science ®Google Scholar
• O’NeillTWFelsenbergDVarlowJCooperCKanisJASilmanAJThe prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis StudyJ Bone Miner Res1996117101010188797123
   PubMed Web of Science ®Google Scholar
• PauwelsRALofdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med1999340251948195310379018
   PubMed Web of Science ®Google Scholar
• KjensliAFalchJARygMHigh prevalence of vertebral deformities in COPD patients: relation to disease severityEur Respir J20093351018102419129288
   PubMed Web of Science ®Google Scholar
• JorgensenNRSchwarzPHolmeIHenriksenBMPetersenLJBackerVThe prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional studyRespir Med2007101117718516677808
   PubMed Web of Science ®Google Scholar
• van StaaTPAbenhaimLCooperCZhangBLeufkensHGPublic health impact of adverse bone effects of oral corticosteroidsBr J Clin Pharmacol200151660160711422020
   PubMed Web of Science ®Google Scholar
• WalshLJWongCAOborneJAdverse effects of oral corticosteroids in relation to dose in patients with lung diseaseThorax200156427928411254818
   PubMed Web of Science ®Google Scholar
• van StaaTPLeufkensHGCooperCThe epidemiology of corticosteroid-induced osteoporosis: a meta-analysisOsteoporos Int2002131077778712378366
   PubMed Web of Science ®Google Scholar
• van StaaTPThe pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosisCalcif Tissue Int200679312913716969593
   PubMed Web of Science ®Google Scholar
• AngeliAGuglielmiGDovioAHigh prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient studyBone200639225325916574519
   PubMed Web of Science ®Google Scholar
• LaneNELukertBThe science and therapy of glucocorticoid-induced bone lossEndocrinol Metab Clin North Am19982724654839669150
   PubMed Web of Science ®Google Scholar
• ReidIREvansMCStapletonJLateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone lossJ Bone Miner Res1992710122112251456089
   PubMed Web of Science ®Google Scholar
• VestergaardPRejnmarkLMosekildeLFracture risk associated with different types of oral corticosteroids and effect of termination of corticosteroids on the risk of fracturesCalcif Tissue Int200882424925718414920
   PubMed Web of Science ®Google Scholar
• de VriesFPouwelsSLammersJWUse of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/ femur fracture: a population-based case-control studyJ Intern Med2007261217017717241182
   PubMed Web of Science ®Google Scholar
• MichelBABlochDAWolfeFFriesJFFractures in rheumatoid arthritis: an evaluation of associated risk factorsJ Rheumatol19932010166616698295176
   PubMed Web of Science ®Google Scholar
• Ramsey-GoldmanRDunnJEHuangCFFrequency of fractures in women with systemic lupus erythematosus: comparison with United States population dataArthritis Rheum199942588289010323443
   PubMed Web of Science ®Google Scholar
• TonFNGunawardeneSCLeeHNeerRMEffects of low-dose prednisone on bone metabolismJ Bone Miner Res200520346447015746991
   PubMed Web of Science ®Google Scholar
• van StaaTPLaanRFBartonIPCohenSReidDMCooperCBone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapyArthritis Rheum200348113224322914613287
   PubMed Web of Science ®Google Scholar
• SteinbuchMYouketTECohenSOral glucocorticoid use is associated with an increased risk of fractureOsteoporos Int200415432332814762652
   PubMed Web of Science ®Google Scholar
• AdachiJDIoannidisGCalcium and vitamin D therapy in corticosteroid-induced bone loss: what is the evidence?Calcif Tissue Int1999654332610485987
   PubMed Web of Science ®Google Scholar
• LukertBPRaiszLGGlucocorticoid-induced osteoporosis: pathogenesis and managementAnn Intern Med199011253523642407167
   PubMed Web of Science ®Google Scholar
• AdinoffADHollisterJRSteroid-induced fractures and bone loss in patients with asthmaN Engl J Med198330952652686866051
   PubMed Web of Science ®Google Scholar
• GluckOSMurphyWAHahnTJHahnBBone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapyArthritis Rheum19812478928987259801
   PubMed Web of Science ®Google Scholar
• RuegseggerPMediciTCAnlikerMCorticosteroid-induced bone loss. A longitudinal study of alternate day therapy in patients with bronchial asthma using quantitative computed tomographyEur J Clin Pharmacol19832556156206662161
   PubMed Web of Science ®Google Scholar
• DuboisEFRoderEDekhuijzenPNZwindermanAESchweitzerDHDual energy X-ray absorptiometry outcomes in male COPD patients after treatment with different glucocorticoid regimensChest200212151456146312006428
   PubMed Web of Science ®Google Scholar
• MatsumotoHIshiharaKHasegawaTUmedaBNiimiAHinoMEffects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients: a 4-year longitudinal studyChest200112051468147311713121
   PubMed Web of Science ®Google Scholar
• ManningPJEvansMCReidIRNormal bone mineral density following cure of Cushing’s syndromeClin Endocrinol (Oxf)19923632292341563076
   PubMed Web of Science ®Google Scholar
• LaanRFvan RielPLvan de PutteLBvan ErningLJvan’t HofMALemmensJALow-dose prednisone induces rapid reversible axial bone loss in patients with rheumatoid arthritis. A randomized, controlled studyAnn Intern Med1993119109639688105737
   PubMed Web of Science ®Google Scholar
• DalleCLBertoldoFValentiMTHistomorphometric analysis of glucocorticoid-induced osteoporosisMicron20053678645652
   Web of Science ®Google Scholar
• ReidIRGlucocorticoid-induced osteoporosisBaillieres Best Pract Res Clin Endocrinol Metab2000142279219811035907
   PubMed Web of Science ®Google Scholar
• WalshLJLewisSAWongCAThe impact of oral corticosteroid use on bone mineral density and vertebral fractureAm J Respir Crit Care Med2002166569169512204867
   PubMed Web of Science ®Google Scholar
• KanisJAJohanssonHOdenAA meta-analysis of prior corticosteroid use and fracture riskJ Bone Miner Res200419689389915125788
   PubMed Web of Science ®Google Scholar
• McKenzieRReynoldsJCO’FallonADecreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trialJ Rheumatol20002792222222610990237
   PubMed Web of Science ®Google Scholar
• BaptistAPReddyRCInhaled corticosteroids for asthma: are they all the same?J Clin Pharm Ther200934111219125898
   PubMed Web of Science ®Google Scholar
• TattersfieldAEHarrisonTWHubbardRBMortimerKSafety of inhaled corticosteroidsProc Am Thorac Soc20041317117516113431
   PubMedGoogle Scholar
• RossiGACerasoliFCazzolaMSafety of inhaled corticosteroids: room for improvementPulm Pharmacol Ther2007201233516359896
   PubMed Web of Science ®Google Scholar
• DrummondMBDasenbrookECPitzMWMurphyDJFanEInhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysisJAMA2008300202407241619033591
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPWSpencerSAndersonJAMaslenTKRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ200032072451297130310807619
   PubMed Web of Science ®Google Scholar
• LipworthBJSystemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysisArch Intern Med1999159994195510326936
   PubMed Web of Science ®Google Scholar
• RichyFBousquetJEhrlichGEInhaled corticosteroids effects on bone in asthmatic and COPD patients: a quantitative systematic reviewOsteoporos Int200314317919012730758
   PubMed Web of Science ®Google Scholar
• Lung Health Study Research GroupEffect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary diseaseN Engl J Med2000343261902190911136260
   PubMed Web of Science ®Google Scholar
• van StaaTPLeufkensHGCooperCUse of inhaled corticosteroids and risk of fracturesJ Bone Miner Res200116358158811277277
   PubMed Web of Science ®Google Scholar
• HubbardRBSmithCJSmeethLHarrisonTWTattersfieldAEInhaled corticosteroids and hip fracture: a population-based case-control studyAm J Respir Crit Care Med200216612 Pt 11563156612406825
   PubMed Web of Science ®Google Scholar
• HubbardRTattersfieldASmithCWestJSmeethLFletcherAUse of inhaled corticosteroids and the risk of fractureChest200613041082108817035441
   PubMed Web of Science ®Google Scholar
• Pujades-RodriguezMSmithCJHubbardRBInhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary diseaseQJM2007100850951717609226
   PubMed Web of Science ®Google Scholar
• LanghammerANorjavaaraEde VerdierMGJohnsenRBjermerLUse of inhaled corticosteroids and bone mineral density in a population based study: the Nord-Trondelag Health Study (the HUNT Study)Pharmacoepidemiol Drug Saf200413856957915317039
   PubMed Web of Science ®Google Scholar
• LanghammerAForsmoSLilleengSJohnsenRBjermerLEffect of inhaled corticosteroids on forearm bone mineral density: the HUNT study, NorwayRespir Med200710181744175217433653
   PubMed Web of Science ®Google Scholar
• WeatherallMJamesKClayJDose-response relationship for risk of non-vertebral fracture with inhaled corticosteroidsClin Exp Allergy20083891451145818537983
   PubMed Web of Science ®Google Scholar
• MasoliMWeatherallMHoltSBeasleyRClinical dose-response relationship of fluticasone propionate in adults with asthmaThorax2004591162014694240
   PubMed Web of Science ®Google Scholar
• MasoliMHoltSWeatherallMBeasleyRDose-response relationship of inhaled budesonide in adult asthma: a meta-analysisEur Respir J200423455255815083753
   PubMed Web of Science ®Google Scholar
• BarnesPJImmunology of asthma and chronic obstructive pulmonary diseaseNat Rev Immunol20088318319218274560
   PubMed Web of Science ®Google Scholar
• AdenugaDYaoHMarchTHSeagraveJRahmanIHistone deacetylase 2 is phosphorylated, ubiquitinated, and degraded by cigarette smokeAm J Respir Cell Mol Biol200940446447318927347
   PubMed Web of Science ®Google Scholar
• BatemanEDHurdSSBarnesPJGlobal strategy for asthma management and prevention: GINA executive summaryEur Respir J200831114317818166595
   PubMed Web of Science ®Google Scholar
• PasaogluGGokHMunganDSonelBYalcinPMisirligilZDoes the combination of inhaled steroids with long acting beta2 agonists decrease the risk for osteoporosis? A 1-year prospective follow-up studyRheumatol Int200627214114616932963
   PubMed Web of Science ®Google Scholar
• AaronSDVandemheenKLFergussonDTiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med2007146854555517310045
   PubMed Web of Science ®Google Scholar
• KardosPWenckerMGlaabTVogelmeierCImpact of salmeterol/ fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2007175214414917053207
   PubMed Web of Science ®Google Scholar
• WedzichaJACalverleyPMSeemungalTAHaganGAnsariZStockleyRAThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• ZhengJPYangLWuYMThe efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPDChest200713261756176317951625
   PubMed Web of Science ®Google Scholar
• CalverleyPMBoonsawatWCsekeZZhongNPetersonSOlssonHMaintenance therapy with budesonide and formoterol in chronic obstructive pulmonary diseaseEur Respir J200322691291914680078
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J2003211748112570112
   PubMed Web of Science ®Google Scholar
• VestboJSorensenTLangePBrixATorrePViskumKLong-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trialLancet199935391671819182310359405
   PubMed Web of Science ®Google Scholar
• FergusonGTAnzuetoAFeiREmmettAKnobilKKalbergCEffect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbationsRespir Med200810281099110818614347
   PubMed Web of Science ®Google Scholar
• MahlerDAWirePHorstmanDEffectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200216681084109112379552
   PubMed Web of Science ®Google Scholar
• HananiaNADarkenPHorstmanDThe efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPDChest2003124383484312970006
   PubMed Web of Science ®Google Scholar
• StallbergBSelroosOVogelmeierCAnderssonEEkstromTLarssonKBudesonide/formoterol as effective as prednisolone plus formoterol in acute exacerbations of COPD. A double-blind, randomised, non-inferiority, parallel-group, multicentre studyRespir Res2009101119228428
   PubMed Web of Science ®Google Scholar
• ManolagasSCJilkaRLBone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosisN Engl J Med199533253053117816067
   PubMed Web of Science ®Google Scholar
• ThornberryNALazebnikYCaspases: enemies withinScience19982815381131213169721091
   PubMed Web of Science ®Google Scholar
• HofbauerLCKhoslaSDunstanCRLaceyDLBoyleWJRiggsBLThe roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorptionJ Bone Miner Res200015121210646108
   PubMed Web of Science ®Google Scholar
• HofbauerLCGoriFRiggsBLStimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosisEndocrinology1999140104382438910499489
   PubMed Web of Science ®Google Scholar
• HardyRCooperMSBone loss in inflammatory disordersJ Endocrinol2009201330932019443863
   PubMed Web of Science ®Google Scholar
• LorenzoJHorowitzMChoiYOsteoimmunology: interactions of the bone and immune systemEndocr Rev200829440344018451259
   PubMed Web of Science ®Google Scholar
• GilbertLHeXFarmerPInhibition of osteoblast differentiation by tumor necrosis factor-alphaEndocrinology2000141113956396411089525
   PubMed Web of Science ®Google Scholar
• CooperMSSensitivity of bone to glucocorticoidsClin Sci (Lond)2004107211112315113280
   PubMed Web of Science ®Google Scholar
• LovasKGjesdalCGChristensenMGlucocorticoid replacement therapy and pharmacogenetics in Addison’s disease: effects on boneEur J Endocrinol20091606993100219282465
   PubMed Web of Science ®Google Scholar
• CanalisEMechanisms of glucocorticoid action in boneCurr Osteoporos Rep2005339810216131429
   PubMedGoogle Scholar
• YaoWChengZBusseCPhamANakamuraMCLaneNEGlucocorticoid excess in mice results in early activation of osteoclastogenesis and adipogenesis and prolonged suppression of osteogenesis: a longitudinal study of gene expression in bone tissue from glucocorticoid-treated miceArthritis Rheum20085861674168618512788
   PubMed Web of Science ®Google Scholar
• WeinsteinRSChenJRPowersCCPromotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoidsJ Clin Invest200210981041104811956241
   PubMed Web of Science ®Google Scholar
• EijkenMKoedamMvanDMBuurmanCJPolsHAvan LeeuwenJPThe essential role of glucocorticoids for proper human osteoblast differentiation and matrix mineralizationMol Cell Endocrinol200624812879316413958
   PubMed Web of Science ®Google Scholar
• CanalisEMazziottiGGiustinaABilezikianJPGlucocorticoid-induced osteoporosis: pathophysiology and therapyOsteoporos Int200718101319132817566815
   PubMed Web of Science ®Google Scholar
• LaneNEYaoWBaloochMGlucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient miceJ Bone Miner Res200621346647616491295
   PubMed Web of Science ®Google Scholar
• O’BrienCAJiaDPlotkinLIGlucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strengthEndocrinology200414541835184114691012
   PubMed Web of Science ®Google Scholar
• EastellRRole of oestrogen in the regulation of bone turnover at the menarcheJ Endocrinol2005185222323415845915
   PubMed Web of Science ®Google Scholar
• MillerKKLeeEELawsonEADeterminants of skeletal loss and recovery in anorexia nervosaJ Clin Endocrinol Metab20069182931293716735492
   PubMed Web of Science ®Google Scholar
• OhnakaKTanabeMKawateHNawataHTakayanagiRGlucocorticoid suppresses the canonical Wnt signal in cultured human osteoblastsBiochem Biophys Res Commun2005329117718115721290
   PubMed Web of Science ®Google Scholar
• HopkinsonNSManWDDayerMJAcute effect of oral steroids on muscle function in chronic obstructive pulmonary diseaseEur Respir J200424113714215293616
   PubMed Web of Science ®Google Scholar
• BonnetNPierrozDDFerrariSLAdrenergic control of bone remodeling and its implications for the treatment of osteoporosisJ Musculoskelet Neuronal Interact2008829410418622078
   PubMedGoogle Scholar
• BonnetNBenhamouCLBrunet-ImbaultBSevere bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female ratsBone200537562263316157516
   PubMed Web of Science ®Google Scholar
• WiensMEtminanMGillSSTakkoucheBEffects of antihypertensive drug treatments on fracture outcomes: a meta-analysis of observational studiesJ Intern Med2006260435036216961672
   PubMed Web of Science ®Google Scholar
• deVFPouwelsSBrackeMUse of beta-2 agonists and risk of hip/femur fracture: a population-based case-control studyPharmacoepidemiol Drug Saf200716661261916998945
   PubMed Web of Science ®Google Scholar
• VestergaardPRejnmarkLMosekildeLFracture risk in patients with chronic lung diseases treated with bronchodilator drugs and inhaled and oral corticosteroidsChest200713251599160717890464
   PubMed Web of Science ®Google Scholar
• FortenberyEJMcDermottMTDuncanWEEffect of theophylline on calcium metabolism and circulating vitamin D metabolitesJ Bone Miner Res1990543213242343772
   PubMed Web of Science ®Google Scholar
• OnerPGurdolFOner-IyidonYKolanciCBuyukozturkSEvaluation of the effect of low-dose oral theophylline therapy on some bone turnover markers and serum prolidase I activity in mild asthmaticsPharmacol Res199940218919310433880
   PubMed Web of Science ®Google Scholar
• CompstonJUS and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differencesCurr Rheumatol Rep200461666914713404
   PubMedGoogle Scholar
• LimLSHoeksemaLJSherinKScreening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practiceAm J Prev Med200936436637519285200
   PubMed Web of Science ®Google Scholar
• KanisJAJohnellOOdenAJohanssonHMcCloskeyEFRAX and the assessment of fracture probability in men and women from the UKOsteoporos Int200819438539718292978
   PubMed Web of Science ®Google Scholar
• KanisJAOdenAJohnellOThe use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and womenOsteoporos Int20071881033104617323110
   PubMed Web of Science ®Google Scholar
• ShakerJLLukertBPOsteoporosis associated with excess glucocorticoidsEndocrinol Metab Clin North Am2005342341–ix15850846
   PubMed Web of Science ®Google Scholar
• CheMEttingerBNguyenMTPressmanARJohnstonJHigh-dose corticosteroid exposure and osteoporosis intervention in adultsAnn Allergy Asthma Immunol200697449750117069105
   PubMed Web of Science ®Google Scholar
• LacasseYBrosseauLMilneSPulmonary rehabilitation for chronic obstructive pulmonary diseaseCochrane Database Syst Rev20023CD00379312137716
   PubMedGoogle Scholar
• CooperCBThe connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and functionAm J Med200611910 Suppl 1213116996896
   PubMed Web of Science ®Google Scholar
• QaseemASnowVShekellePHopkinsRJrForcieaMAOwensDKPharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of PhysiciansAnn Intern Med2008149640441518794560
   PubMed Web of Science ®Google Scholar
• TangBMEslickGDNowsonCSmithCBensoussanAUse of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysisLancet2007370958865766617720017
   PubMed Web of Science ®Google Scholar
• GuGHentunenTANarsMHarkonenPLVaananenHKEstrogen protects primary osteocytes against glucocorticoid-induced apoptosisApoptosis200510358359515909120
   PubMed Web of Science ®Google Scholar
• Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced OsteoporosisArthritis Rheum20014471496150311465699
   PubMed Web of Science ®Google Scholar
• van StaaTPLeufkensHGAbenhaimLZhangBCooperCOral corticosteroids and fracture risk: relationship to daily and cumulative dosesRheumatology (Oxford)200039121383138911136882
   PubMed Web of Science ®Google Scholar
• AminSLavalleyMPSimmsRWFelsonDTThe comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regressionJ Bone Miner Res20021781512152612162505
   PubMed Web of Science ®Google Scholar
• PlotkinLIAguirreJIKousteniSManolagasSCBellidoTBisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activationJ Biol Chem200528087317732515590626
   PubMed Web of Science ®Google Scholar
• SaagKGShaneEBoonenSTeriparatide or alendronate in glucocorticoid-induced osteoporosisN Engl J Med2007357202028203918003959
   PubMed Web of Science ®Google Scholar
• LangdahlBLMarinFShaneETeriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal statusOsteoporos Int200947 [Epub ahead of print]
   Web of Science ®Google Scholar
• O’DonnellSCranneyAWellsGAAdachiJDReginsterJYStrontium ranelate for preventing and treating postmenopausal osteoporosisCochrane Database Syst Rev20064CD005326
   Web of Science ®Google Scholar